External auditory canal and middle ear involvement is an uncommon initial presentation for early primary nasopharyngeal carcinoma. Previously reported cases were only associated with advanced skull base erosion or recurrence after radical treatment. We present a patient with nasopharyngeal carcinoma with a small inconspicuous primary tumour in the nasopharynx without skull base erosion, but who first presented with auditory symptoms and was found to have biopsy-proven external auditory canal involvement. Contrastenhanced magnetic resonance imaging and 18 F-fluorodeoxyglucose-positron emission tomography clearly demonstrated the route of extension via the Eustachian tube into the middle ear and mastoid air cells. This report highlights the importance of heightened vigilance for nasopharyngeal carcinoma and careful nasal endoscopic examination when encountering an undifferentiated carcinoma of the external auditory canal, especially in areas endemic for nasopharyngeal carcinoma. Similarly, otoscopic examination and modern imaging techniques such as magnetic resonance imaging or positron emission tomography are invaluable for investigating suspected nasopharyngeal carcinoma that presents as auditory symptoms.
INTRODUCTION
We report a patient with rare external auditory canal (EAC) and middle ear involvement by an inconspicuous primary nasopharyngeal carcinoma (NPC) via spread through the Eustachian tube (ET) at first presentation.
CASE REPORT
In November 2013, a 42-year-old man of good past health presented to an otolaryngologist with hearing impairment and a 'blocked sensation' in the left ear for 2 months. There was also intermittent blood-stained discharge from the left ear. There was no associated nasal symptom, nor were there any cranial nerve deficits or palpable cervical lymph nodes.
The initial otoscopic finding was granulation tissue with contact bleeding in the left EAC. Magnetic resonance imaging (MRI) of the left ear showed a soft tissue lesion within the left middle ear cavity abutting the cochlear promontory. The lesion demonstrated contrast enhancement in post-gadolinium images. The lesion extended anteriorly into the left ET and posteriorly into the aditus, and was associated with congestion of the mastoid air cells. A small extension of contrast enhancement was noted in the mastoid air cells, just lateral to the semi-circular canal. The MRI diagnosis was a glomus tympanicum paraganglioma. The nasopharynx was uniformly thickened with slight contrast enhancement over the left side, but no bulky mass was shown (Figures 1 to 3 ). Computed tomography (CT) of the left temporal bone also showed a soft tissue lesion occupying the left middle ear cavity, which had blocked the mastoid air cells as well as the ET. Bony erosion was not evident on CT. The CT finding was non-specific and the differential diagnoses included inflammatory tissues, a cholesteatoma, or an extensive glomus tumour (Figures 1 and 2 ).
Repeated otoscopy revealed hyperaemic non-pulsatile nodules over the posterior-inferior and posterior walls Tissue biopsies taken from the left EAC nodules and the nasopharynx were both infiltrated by undifferentiated carcinoma cells with oval nuclei and distinct nucleoli with background chronic inflammatory cells. In the EAC specimen, the carcinoma cells were positive for cytokeratin. Staining for synaptophysin and S100 protein were negative. In-situ hybridisation for EpsteinBarr virus encoded-RNA was positive, compatible with NPC of a non-keratinising undifferentiated type ( Figures  5 and 6 ). To complete the tumour staging,
18
F-fluorodeoxyglucose (FDG) positron emission tomography (PET)-CT was performed. Soft tissue thickening with mild FDG hypermetabolism of maximum standardised uptake value (SUV max ) of 2.9 was noted in the left side of the nasopharynx, obliterating the left fossa of Rosenmuller. There was extension of FDG hypermetabolism across the midline and posterolaterally to the bilateral foramina ovale. No gross bony erosion over the skull base was depicted. There was increased FDG uptake along the left ET with SUV max of 4.7. FDG hypermetabolism was noted at the left inner and middle ear, and possibly part of the congested left mastoid air cells, which was suspicious of malignant involvement (Figure 1) . No regional lymph nodes or distant metastasis were noted.
Overall, the radiological and pathological findings were compatible with locally advanced NPC with left ET, middle ear, and EAC involvement.
Primary radical chemo-irradiation was offered to the patient. However, he refused treatment because of fear of treatment-related toxicities and after thorough discussion of advantages and disadvantages. His wish was respected.
DISCUSSION
NPC is rare in most parts of the world, with onset rates of less than 1 per 10,000 of all cancers.
1 Nonetheless, it is endemic in certain areas, such as Southeast China. The highest incidence of NPC has been observed in Hong Kong, where it ranked the seventh commonest cancer in 2011, with an incidence of 12.2% per 100,000 population. 2 The commonest presentation of NPC is cervical lymphadenopathy, although nasal symptoms (discharge, bleeding, obstruction) and otologic symptoms (tinnitus, deafness, pain, discharge) should also evoke clinical suspicion. Auditory symptoms are the main presenting symptoms in 18% of patients 3 and a middle ear effusion is found in 38% of patients first diagnosed with NPC. 4, 5 Many theories have been postulated for the mechanism of secretory otitis media resulting from ET tube dysfunction in NPC. One of the most popularly discussed theories is paralysis of the tensor veli palatini muscle. The tensor veli palatini muscle actively dilates the ET during swallowing. The nerve for the tensor veli palatini muscle passes through the superior part of the parapharyngeal space. In a cross-sectional imaging and electromyography study, the tensor veli palatini muscle was paralysed in 67% of symptomatic ears, suggesting invasion or compression of the nerve by a T2 NPC. 6 Middle ear effusion has also been found to be associated with major displacement of the cartilaginous ET by a tumour. 7 Direct NPC invasion into the middle ear is rare. In an MRI series of 102 'sides' of nasopharynx involving NPC, only 13 had invasion of the cartilaginous ET, and none had invasion of the lumen of the bony ET or middle ear. 7 Only six NPC patients with middle ear extension have been reported in the English-language literature, and most were recurrences after primary treatment with radical (chemo)radiotherapy. [8] [9] [10] [11] [12] Two more patients have been reported in Turkish, 13 and a case series has been written in Chinese, which included nine NPC patients with tumour growth in the EAC, of which three were found at first diagnosis and six occurred during recurrence. 14 Similar to this patient, the reported patients commonly presented with ear discharge, hearing deficit, and otalgia; and careful otoscopic examination often found EAC polyps. A lower motor neuron type of facial nerve palsy was another interesting manifestation. [11] [12] [13] CT always showed soft tissue mass in the middle ear cavity, frequently with associated skull base bone destruction and mastoid air cell involvement. 9, 11 Most of the earlier patients did not undergo MRI or PET. In patients with recurrence, most did not recur in the nasopharynx, and many subsequently developed distant metastases despite aggressive local salvage treatment, including mastoidectomy with or without adjuvant radiotherapy, 9, 11 and upfront re-irradiation concurrent with chemotherapy. 14 In this patient, the route of invasion to the middle ear was through the ET as evidenced by the contrast enhancement on MRI and the SUV uptake on PET along its course. Direct tumour invasion of the ET has been documented by MRI studies, although for reasons that are unclear, this has rarely been reported. 7, 15 Interestingly, in this patient, there was little erosion of the surrounding temporal bone. This could point to true mucosal or submucosal spread along the ET, rather than a locally advanced NPC invading the ET and middle ear externally through extensive skull bone involvement. The tumour was suspected to further reach the mastoid air cells, which communicate with the middle ear posteriorly via the tympanic antrum. True malignant involvement was difficult to differentiate from congestion on CT or MRI, but seemed likely as only part of the congested mastoid air cells demonstrated contrast enhancement on MRI and FDG hypermetabolism on PET. In contrast, in some of the previously reported patients, more extensive and destructive, hence radiologically more obvious, tumour involvement of the mastoid air cells was noted. 16 If this patient had agreed to radical radiotherapy, we would have co-registered the PET images to the planning CT images and included the FDG-avid mastoid air cells as part of the gross tumour volume.
The radiological differential diagnosis for this patient was glomus tympanicum paraganglioma. Paraganglioma are slow-growing vascular tumours that arise from neuroectodermal paraganglion cells located near nerves and vasculature. Although glomus tympanicum, arising along the inferior tympanic nerve, is the most common primary tumour of the middle ear, glomus tumours are generally rare. In contrast, NPC is endemic in Hong Kong. 2 In this patient, the otolaryngologist has demonstrated high clinical vigilance in performing a nasal endoscopy to look for spread from a nasopharyngeal primary tumour, even in the absence of a bulky NPC on radiological imaging.
CONCLUSION
This patient highlights the importance of careful endoscopic examination and biopsy of the nasopharynx to actively exclude primary NPC when encountering an undifferentiated carcinoma of the EAC, particularly in regions endemic for NPC. Similarly, otoscopic examination and modern imaging techniques such as MRI or PET are invaluable for investigating a suspected NPC that presents as auditory symptoms. Clinically inconspicuous NPC may involve the middle ear and EAC via the ET in the absence of a bulky primary tumour or significant skull base destruction. Similar vigilance should be applied when investigating auditory symptoms after radiotherapy, even though post-treatment toxicity to the auditory apparatus is common. Without bearing these possibilities in mind, we may consequently delay detection of disease in sites amenable to radical primary or salvage treatment.
